A decrease in the levels of glucose transporters in both neurons (GLUT1) and BBB (GLUT3) in AD patients, raised the hypothesis that these transporters may have a role in the impairment of glucose uptake and metabolism in the brain, which can trigger the phosphorylation of tau protein (Michalicova et al., 2017). Here, SLC2A1 is linked to Alzheimer disease.